The ATRX Gene Alpha-thalassemia/mental retardation syndrome genetic test is a specialized diagnostic tool designed to detect mutations in the ATRX gene, which can lead to alpha-thalassemia/mental retardation syndrome. This condition is characterized by a combination of alpha-thalassemia, a blood disorder affecting hemoglobin production, and intellectual disabilities. The test is critical for early diagnosis and management of the syndrome, enabling healthcare providers to offer appropriate treatments and interventions.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test ensures high accuracy and reliability. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to analyze the ATRX gene mutations accurately. DNA Labs UAE employs state-of-the-art genetic sequencing techniques, providing patients and their families with crucial information about the genetic basis of alpha-thalassemia/mental retardation syndrome and guiding decisions about care and management.
The SPTB gene anemia, specifically concerning neonatal hemolytic conditions that are fatal or near-fatal, is a critical area of genetic testing offered by DNA Labs UAE. This condition is characterized by the destruction of red blood cells leading to severe anemia in newborns, which can be life-threatening if not diagnosed and treated promptly. The SPTB gene plays a crucial role in the structural integrity of red blood cells, and mutations in this gene can lead to their premature breakdown, a condition known as hereditary spherocytosis.
DNA Labs UAE provides a comprehensive genetic test aimed at detecting mutations in the SPTB gene, which is vital for families with a history of neonatal hemolytic anemia or for those newborns presenting symptoms related to this condition. Early detection through this genetic testing can facilitate timely interventions, potentially saving lives or significantly improving the quality of life for affected infants.
The cost of the SPTB gene anemia test at DNA Labs UAE is set at 4400 AED. This investment covers the meticulous process of DNA analysis to identify the specific mutations within the SPTB gene that are responsible for the condition. Given the complexity and the specialized nature of this genetic testing, the price reflects both the technological and professional expertise required to deliver accurate and reliable results.
Families considering this test can rest assured that DNA Labs UAE utilizes state-of-the-art genetic sequencing technology, providing them with critical information that can guide medical decisions from an early stage of their child's life. This test is not only a tool for diagnosis but also an essential step in planning the appropriate medical management for affected newborns, potentially averting fatal or severe outcomes associated with neonatal hemolytic anemia.
The GLRX5 gene plays a crucial role in the human body's iron metabolism and red blood cell production. Mutations in this gene can lead to a condition known as sideroblastic anemia, specifically a form that is pyridoxine-refractory and inherited in an autosomal recessive manner. This means that individuals with this condition do not respond to the usual treatment with vitamin B6 (pyridoxine) and must inherit two copies of the mutated gene, one from each parent, to manifest the disease. Sideroblastic anemia is characterized by the body's inability to properly incorporate iron into hemoglobin, leading to a form of anemia where the bone marrow produces ringed sideroblasts instead of healthy red blood cells.
To diagnose this specific genetic condition, a genetic test targeting the GLRX5 gene can be conducted. DNA Labs UAE offers such a test, providing a comprehensive analysis to identify mutations in the GLRX5 gene that are responsible for sideroblastic anemia. This genetic test is crucial for accurate diagnosis, allowing for appropriate management and treatment strategies to be implemented for affected individuals. The test is priced at 4400 AED and is conducted in a state-of-the-art laboratory setting, ensuring high-quality and reliable results.
The SLC25A38 gene plays a crucial role in the body, and mutations in this gene are linked to a specific type of anemia known as sideroblastic anemia, which is pyridoxine-refractory and autosomal recessive. This condition is characterized by the body's inability to properly incorporate iron into hemoglobin, leading to a buildup of iron in red blood cells and causing them to have a ringed appearance. Unlike other forms of anemia that might respond to vitamin B6 (pyridoxine) supplements, this condition does not improve with such treatment, hence the term "pyridoxine-refractory."
To diagnose this genetic condition, DNA Labs UAE offers a specialized genetic test targeting the SLC25A38 gene. This test is essential for accurately diagnosing the disorder, enabling healthcare providers to tailor treatment plans that address the specific needs of patients with this form of anemia. The cost of the test is 4400 AED, reflecting the specialized analysis and the detailed insights it provides into the patient's genetic makeup. This test is particularly valuable for individuals exhibiting symptoms of sideroblastic anemia or those with a family history of the condition, as it helps in making informed decisions regarding management and treatment strategies.
The NANOS1 Gene Oligo-astheno-teratozoospermia Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the NANOS1 gene that are associated with oligo-astheno-teratozoospermia (OAT), a condition affecting male fertility. OAT is characterized by a low sperm count (oligospermia), poor sperm motility (asthenozoospermia), and abnormal sperm morphology (teratozoospermia), which can significantly reduce a man's ability to father children. The test is crucial for individuals or couples facing infertility issues, as it provides essential genetic information that can guide treatment options and reproductive planning. Conducted with advanced genetic analysis technologies, this test ensures accurate and reliable results. The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. By choosing to undergo this genetic test at DNA Labs UAE, individuals can gain valuable insights into their reproductive health, empowering them with the information needed to make informed decisions about their fertility journey.
The ZP1 Gene Oocyte Maturation Defect Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the ZP1 gene, which can lead to oocyte maturation defects. The ZP1 gene plays a crucial role in the development and maturation of oocytes, which are essential for successful fertilization and subsequent embryo development. Mutations in this gene can result in infertility or subfertility in women, making this test particularly relevant for those experiencing difficulties in conceiving.
This genetic test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any abnormalities in the ZP1 gene. The test is priced at 4400 AED and provides valuable insights for individuals or couples facing infertility issues, helping them to understand the underlying genetic factors and guiding them towards appropriate fertility treatments or interventions.
DNA Labs UAE, known for its state-of-the-art facilities and expert team of geneticists and clinicians, ensures high accuracy and reliability of the test results, making it a trusted choice for genetic testing in the region.
The SOHLH1 gene plays a crucial role in the process of oogenesis, which is the development of female gametes or eggs. Mutations or dysfunctions in this gene can lead to various reproductive and fertility issues in women. To address this, a specific genetic test has been developed to identify anomalies in the SOHLH1 gene, thereby helping in the diagnosis and management of related fertility problems.
This genetic test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, and analyzing it for any irregularities in the SOHLH1 gene that could impair oogenesis. This precise identification aids healthcare providers in tailoring treatment and counseling for individuals or couples facing fertility challenges.
The cost of the SOHLH1 Gene Oogenesis Dysfunction Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis and detailed reporting necessary for a conclusive diagnosis. It is a critical step for those who have faced difficulties with fertility and are seeking specific answers and solutions tailored to their genetic makeup.
The FSHR Gene Ovarian Dysgenesis Type 1 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the FSHR gene, which are linked to Ovarian Dysgenesis Type 1. This condition is a form of primary ovarian insufficiency, where the ovaries do not develop properly, leading to issues with fertility and potentially causing early menopause among affected women. The FSHR gene plays a crucial role in the reproductive system, particularly in the development and function of the ovaries. Mutations in this gene can disrupt normal ovarian development and function, making this test crucial for early diagnosis and management of the condition.
Priced at 4400 AED, the test provides individuals and families with critical information regarding genetic predispositions that could affect ovarian health and fertility. Conducted at DNA Labs UAE, a facility renowned for its cutting-edge technology and expertise in genetic diagnostics, this test is a valuable resource for those seeking to understand their reproductive health better. Early detection through this genetic testing can facilitate timely interventions and informed decisions regarding fertility planning and management, enhancing the quality of life for those affected by Ovarian Dysgenesis Type 1.
The BMP15 Gene Ovarian Dysgenesis Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the BMP15 gene, which are associated with Ovarian Dysgenesis Type 2. This condition is a form of primary ovarian insufficiency, where the ovaries do not develop properly, leading to infertility and other hormonal imbalances in affected women. The BMP15 gene plays a crucial role in the development of ovarian follicles, and mutations in this gene can disrupt normal ovarian function, leading to the condition.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for specific genetic alterations in the BMP15 gene. The results can provide valuable information for the diagnosis and management of Ovarian Dysgenesis Type 2, helping healthcare providers to tailor treatment and counseling options for affected individuals and their families.
The cost of the BMP15 Gene Ovarian Dysgenesis Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This price may cover the collection of the sample, the genetic analysis, and the provision of a comprehensive report detailing the findings. Patients considering this test should consult with their healthcare provider to understand its benefits and implications fully.
The "AMH Gene Persistent Mullerian Duct Syndrome Type 1 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the Anti-Müllerian Hormone (AMH) gene. This condition, known as Persistent Müllerian Duct Syndrome (PMDS) type 1, is a rare form of intersex disorder where individuals with a typically male XY chromosome pattern exhibit both male and female internal reproductive organs due to the failure of the Müllerian ducts to regress during fetal development. The AMH gene plays a crucial role in this process, and mutations can lead to the syndrome.
The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, which is equipped with advanced genetic testing technologies. By analyzing the patient's DNA, the test can identify specific mutations in the AMH gene, providing essential information for diagnosis, management, and counseling of affected individuals and their families. This genetic test is vital for understanding the underlying genetic cause of PMDS type 1 and can aid in the appropriate clinical management of the condition.
